EP
AVNS

Essential Partners’s Avanos Medical AVNS Stock Holding History

Essential Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3K Buy
2,306
+31
+1% +$418 0.01% 743
2025
Q4 		$25.5K Sell
2,275
-1,415
-38% -$16.2K 0.01% 819
2025
Q3 		$42.7K Buy
3,690
+2,801
+315% +$32.8K 0.01% 639
2025
Q2 		$10.9K Buy
+889
New +$11.2K ﹤0.01% 823

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Essential Partners's AVNS Position: Q1 2026 in Review

Essential Partners increased its Avanos Medical (AVNS) stake by 1.4% in Q1 2026, buying an estimated $418 and bringing the position to 2,306 shares worth $32.3K. The position accounts for 0.01% of the portfolio, ranked #743.

Essential Partners first reported a position in AVNS in Q2 2025 and has held it in 4 quarters since. The position peaked at $42.7K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Essential Partners held 2,306 shares of Avanos Medical worth $32.3K as of Q1 2026.
  • Essential Partners bought 31 Avanos Medical shares in Q1 2026, an estimated $418.
  • Avanos Medical made up 0.01% of Essential Partners's portfolio in Q1 2026, its #743 holding.
  • Essential Partners first reported a position in Avanos Medical in Q2 2025 and has held it in 4 quarters since.
  • Essential Partners's Avanos Medical position peaked at $42.7K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.